Peripartum cardiomyopathy in Turkey: Experience of three tertiary centres
dc.contributor.author | Akil, Mehmet Ata | |
dc.contributor.author | Bilik, Mehmet Zihni | |
dc.contributor.author | Yildiz, Abdulkadir | |
dc.contributor.author | Acet, Halit | |
dc.contributor.author | Ertas, Faruk | |
dc.contributor.author | Simsek, Hakki | |
dc.contributor.author | Polat, Nihat | |
dc.date.accessioned | 2024-04-24T17:20:26Z | |
dc.date.available | 2024-04-24T17:20:26Z | |
dc.date.issued | 2016 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description.abstract | We conducted this study to determine demographic details, and clinical presentations in patients with peripartum cardiomyopathy (PPCMP) of Turkish origin. The study population consisted of 58 patients with PPCMP treated at 3 major hospitals in Turkey, retrospectively. In this study, demographic details and initial echocardiographic data were recorded and long-term clinical status was evaluated. The mean age for the patient cohort was 31.47 +/- 6.31 years. Thirty-eight patients (73.1%) were multigravida and seven patients had multifetal pregnancy (13.7%). The mean follow-up left ventricular (LV) ejection fraction increased from 31 +/- 7 to 38 +/- 19. A minority of patients were defined as improvers according to our pre-specified criteria. The average survival period after diagnosis of PPCMP was 20.66 +/- 14.44 months. Initial values for LV end-diastolic diameter and urea were higher in the deceased patients compared with the surviving patients, respectively. Twenty-eight (48%) patients with PPCMP showed improvement in the follow-up period. Of the 58 PPCMP patients, 9 (15%) died during a mean follow-up of 32 +/- 22 months. | en_US |
dc.identifier.doi | 10.3109/01443615.2015.1107531 | |
dc.identifier.endpage | 580 | en_US |
dc.identifier.issn | 0144-3615 | |
dc.identifier.issn | 1364-6893 | |
dc.identifier.issue | 5 | en_US |
dc.identifier.pmid | 26789488 | |
dc.identifier.scopus | 2-s2.0-84955115255 | |
dc.identifier.scopusquality | Q3 | |
dc.identifier.startpage | 574 | en_US |
dc.identifier.uri | https://doi.org/10.3109/01443615.2015.1107531 | |
dc.identifier.uri | https://hdl.handle.net/11468/19048 | |
dc.identifier.volume | 36 | en_US |
dc.identifier.wos | WOS:000377043100004 | |
dc.identifier.wosquality | Q4 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | en_US |
dc.publisher | Taylor & Francis Inc | en_US |
dc.relation.ispartof | Journal of Obstetrics and Gynaecology | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Heart Failure | en_US |
dc.subject | Peripartum Cardiomyopathy | en_US |
dc.subject | Pregnancy | en_US |
dc.subject | Systolic Dysfunction | en_US |
dc.title | Peripartum cardiomyopathy in Turkey: Experience of three tertiary centres | en_US |
dc.title | Peripartum cardiomyopathy in Turkey: Experience of three tertiary centres | |
dc.type | Article | en_US |